Article Information
History
- June 9, 2020.
Article Versions
- Version 1 (May 26, 2020 - 04:48).
- Version 2 (May 27, 2020 - 08:18).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sonny M Assennatoa,*,
- Allyson V Ritchiea,*,
- Cesar Nadalab,
- Neha Goela,
- Hongyi Zhangc,
- Rawlings Datird,
- Ravindra K Guptae,f,
- Martin D Curranc,** and
- Helen H Leea,b,**,#
- aDiagnostics for the Real World EU Ltd., Chesterford Research Park, Great Chesterford, UK
- bDiagnostics for the Real World Ltd., San Jose, USA
- cClinical Microbiology and Public Health Laboratory, PHE Cambridge, Addenbrooke’s Hospital, Cambridge, UK
- dDivision of Infection and Immunity, University College London, London, UK
- eDepartment of Medicine, University of Cambridge, Cambridge, UK
- fAfrica Health Research Institute, Durban, South Africa
- ↵#Address correspondence to Dr Helen H Lee, email: hl207{at}cam.ac.uk
Posted June 09, 2020.
Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2
